AHCY and metabolic dysfunction-associated steatohepatitis: Obesity, and the non-alcoholic fatty liver disease (NAFLD) and more severe nonalcoholic steatohepatitis, that accompanies it, is associated with severe dysfunction of glutathione-related enzymes [35,36] and inhibition of SAHH activity [37].